Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) Research & Development (2018 - 2025)

Historic Research & Development for Evolus (EOLS) over the last 8 years, with Q3 2025 value amounting to $2.0 million.

  • Evolus' Research & Development fell 1158.17% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year decrease of 654.46%. This contributed to the annual value of $9.2 million for FY2024, which is 3990.24% up from last year.
  • Per Evolus' latest filing, its Research & Development stood at $2.0 million for Q3 2025, which was down 1158.17% from $1.8 million recorded in Q2 2025.
  • Evolus' Research & Development's 5-year high stood at $2.4 million during Q4 2024, with a 5-year trough of $301000.0 in Q3 2021.
  • Over the past 5 years, Evolus' median Research & Development value was $1.5 million (recorded in 2022), while the average stood at $1.5 million.
  • Examining YoY changes over the last 5 years, Evolus' Research & Development showed a top increase of 35714.29% in 2022 and a maximum decrease of 4435.2% in 2022.
  • Over the past 5 years, Evolus' Research & Development (Quarter) stood at $423000.0 in 2021, then soared by 218.68% to $1.3 million in 2022, then skyrocketed by 76.56% to $2.4 million in 2023, then grew by 2.1% to $2.4 million in 2024, then decreased by 15.8% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $1.8 million for Q2 2025, and $2.2 million during Q1 2025.